Nateglinide (Avera McKennan Hospital)
Welcome to the PulseAid listing for the Nateglinide drug offered from Avera McKennan Hospital. This Glinide [EPC],Potassium Channel Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Avera McKennan Hospital |
NON-PROPRIETARY NAME: | Nateglinide |
SUBSTANCE NAME: | NATEGLINIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Glinide [EPC],Potassium Channel Antagonists [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, COATED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2016-02-22 |
END MARKETING DATE: | 0000-00-00 |
Nateglinide HUMAN PRESCRIPTION DRUG Details:
Item Description | Nateglinide from Avera McKennan Hospital |
LABELER NAME: | Avera McKennan Hospital |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 60(mg/1) |
START MARKETING DATE: | 2016-02-22 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 69189-0984_514fc039-2e1a-428d-92d1-7e793f864c94 |
PRODUCT NDC: | 69189-0984 |
APPLICATION NUMBER: | ANDA077463 |
Other NATEGLINIDE Pharmaceutical Manufacturers / Labelers: